Lexpos News

View the first article on NMS myth busting The post NMS myth busting series (#2) appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis (Fresenius Medical Care Deutschland GmbH) DMRC reference number: DMRC- 39439934 Date issued: 14 May 2026 Fresenius Medical Care Deutschland GmbH have identified an error in the Braille printed on the outer label. Marketing Authorisation Holder: Fresenius Medical Care Deutschland GmbH [...]

The post MHRA Class 4 Medicines Defect Notification: balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis (Fresenius Medical Care Deutschland GmbH) appeared first on Community Pharmacy England.

    The post NMS myth busting series (#1) appeared first on Community Pharmacy England.

Community Pharmacy England’s annual regional roadshow series returns in less than a month, kicking off with events in Yorkshire & the North East in the first week of June. The series of interactive evening sessions will bring local pharmacies together with the people negotiating on their behalf to talk openly about funding, the challenges facing [...]

The post We’re coming to a town near you appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Loperamide hydrochloride 2 mg Orodispersible Tablets (Milpharm Ltd) Drug alert number: EL(26)A/23 Date issued: 11 May 2026 Milpharm Limited has identified a discrepancy in the Patient Information Leaflet (PIL) approved for Loperamide hydrochloride 2 mg Orodispersible Tablets. DMRC reference number: DMRC- 39394163 Marketing Authorisation Holder: Milpharm Limited Medicine Details Product name: [...]

The post MHRA Class 4 Medicines Defect Notification: Loperamide hydrochloride 2 mg Orodispersible Tablets (Milpharm Ltd) appeared first on Community Pharmacy England.